Clinical Trial Update: A Study to Learn About Zavegepant as the Acute Treatment of Migraine in Asian Adults [Phase 3]

View source ↗

Summary

Pfizer conducted a Phase 3 trial evaluating zavegepant for the acute treatment of migraine in Asian adults. The study has completed, according to the update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Zavegepant (zavegepant)

Snippet

Sponsor: Pfizer | Conditions: Migraine | Phase 3 | Status: COMPLETED